相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Bisphosphonate Therapy, Death, and Cardiovascular Events Among Female Patients With CKD: A Retrospective Cohort Study
James E. Hartle et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2012)
FRAX(A (R)) with and without Bone Mineral Density
John A. Kanis et al.
CALCIFIED TISSUE INTERNATIONAL (2012)
The Women's Health Initiative - a decade of progress
Anna Fenton et al.
CLIMACTERIC (2012)
Have we come full circle - or moved forward? The Women's Health Initiative 10 years on
R. D. Langer et al.
CLIMACTERIC (2012)
Assessment of hand trabecular bone texture with high resolution direct digital radiograph in rheumatoid arthritis: A case control study
Anne Fouque-Aubert et al.
JOINT BONE SPINE (2012)
2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis
Karine Briot et al.
JOINT BONE SPINE (2012)
Denosumab reduces the risk of osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAX
Eugene V. McCloskey et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Response to misclassification does not explain increased cardiovascular risks of calcium supplements
Joshua R. Lewis et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Misclassification Does Not Explain Increased Cardiovascular Risks of Calcium Supplements
Mark J. Bolland et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Adverse events from calcium supplementation: Relationship to errors in myocardial infarction self-reporting in randomized controlled trials of calcium supplementation
Joshua R. Lewis et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures
Matthew Austin et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Five years of denosumab exposure in women with postmenopausal osteoporosis: Results from the first two years of the FREEDOM extension
Socrates Papapoulos et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
FRAX underestimates fracture risk in patients with diabetes
Lora M. Giangregorio et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
The effect of prior bisphosphonate therapy on the subsequent therapeutic effects of strontium ranelate over 2 years
E. T. Middleton et al.
OSTEOPOROSIS INTERNATIONAL (2012)
Pitfalls in the external validation of FRAX
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2012)
High fracture probability with FRAX((R)) usually indicates densitometric osteoporosis: implications for clinical practice
W. D. Leslie et al.
OSTEOPOROSIS INTERNATIONAL (2012)
Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosis
J-Y. Reginster et al.
OSTEOPOROSIS INTERNATIONAL (2012)
Quantitative ultrasound of the heel and fracture risk assessment: an updated meta-analysis
A. Moayyeri et al.
OSTEOPOROSIS INTERNATIONAL (2012)
Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study
S. L. Silverman et al.
OSTEOPOROSIS INTERNATIONAL (2012)
A reappraisal of generic bisphosphonates in osteoporosis
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2012)
Fracture risk assessment without bone density measurement in routine clinical practice
W. D. Leslie et al.
OSTEOPOROSIS INTERNATIONAL (2012)
A comparison of case-finding strategies in the UK for the management of hip fractures
H. Johansson et al.
OSTEOPOROSIS INTERNATIONAL (2012)
Reduced colon cancer incidence and mortality in postmenopausal women treated with an oral bisphosphonate-Danish National Register Based Cohort Study
M. Pazianas et al.
OSTEOPOROSIS INTERNATIONAL (2012)
Adverse Reactions and Drug-Drug Interactions in the Management of Women with Postmenopausal Osteoporosis
Rene Rizzoli et al.
CALCIFIED TISSUE INTERNATIONAL (2011)
Current options for the management of postmenopausal osteoporosis
Marie-Paule Lecart et al.
EXPERT OPINION ON PHARMACOTHERAPY (2011)
Calcium supplements and cardiovascular disease - picking the spin
A. Grey et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2011)
Association of BMD and FRAX Score With Risk of Fracture in Older Adults With Type 2 Diabetes
Ann V. Schwartz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Calcium Supplementation and the Risks of Atherosclerotic Vascular Disease in Older Women: Results of a 5-Year RCT and a 4.5-Year Follow-up
Joshua R. Lewis et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Bone Microarchitecture Assessed by TBS Predicts Osteoporotic Fractures Independent of Bone Density: The Manitoba Study
Didier Hans et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Balloon Kyphoplasty for the Treatment of Acute Vertebral Compression Fractures: 2-Year Results From a Randomized Trial
Steven Boonen et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Effects of Denosumab on Bone Turnover Markers in Postmenopausal Osteoporosis
Richard Eastell et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Spine-Hip T-Score Difference Predicts Major Osteoporotic Fracture Risk Independent of FRAX®: A Population-Based Report From CAMOS
William D. Leslie et al.
JOURNAL OF CLINICAL DENSITOMETRY (2011)
Joint Official Positions of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®
Didier B. Hans et al.
JOURNAL OF CLINICAL DENSITOMETRY (2011)
Correlations Between Trabecular Bone Score, Measured Using Anteroposterior Dual-Energy X-Ray Absorptiometry Acquisition, and 3-Dimensional Parameters of Bone Microarchitecture: An Experimental Study on Human Cadaver Vertebrae
Didier Hans et al.
JOURNAL OF CLINICAL DENSITOMETRY (2011)
Comparison of radiograph-based texture analysis and bone mineral density with three-dimensional microarchitecture of trabecular bone
P. Ranjanomennahary et al.
MEDICAL PHYSICS (2011)
Relationship between bone mineral density changes and risk of fractures among patients receiving calcium with or without vitamin D supplementation: a meta-regression
V. Rabenda et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Spine-hip discordance and fracture risk assessment: a physician-friendly FRAX enhancement
W. D. Leslie et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report
R. Rizzoli et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards
S. Vasikaran et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Safety and tolerability of bazedoxifene in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled phase 3 trial
T. J. de Villiers et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis
B. Jonsson et al.
OSTEOPOROSIS INTERNATIONAL (2011)
The calcium scare-what would Austin Bradford Hill have thought?
B. E. C. Nordin et al.
OSTEOPOROSIS INTERNATIONAL (2011)
A meta-analysis of the effect of strontium ranelate on the risk of vertebral and non-vertebral fracture in postmenopausal osteoporosis and the interaction with FRAX®
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Re: The calcium scare: what would Austin Bradford Hill have thought?
M. J. Bolland et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Guidance for the adjustment of FRAX according to the dose of glucocorticoids
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Towards a diagnostic and therapeutic consensus in male osteoporosis
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Partial adherence: a new perspective on health economic assessment in osteoporosis
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Interpretation and use of FRAX in clinical practice
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Clinical Efficacy and Safety of Denosumab in Postmenopausal Women with Low Bone Mineral Density and Osteoporosis: A Meta-Analysis
Camilla von Keyserlingk et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2011)
A Meta-Analysis of Osteoporotic Fracture Risk with Medication Nonadherence
Susan Ross et al.
VALUE IN HEALTH (2011)
Osteoporosis: burden, health care provision and opportunities in the EU
O. Ström et al.
Archives of Osteoporosis (2011)
Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis
Mark J. Bolland et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Predicting risk of osteoporotic and hip fracture in the United Kingdom: prospective independent and external validation of QFractureScores
Gary S. Collins et al.
BRITISH MEDICAL JOURNAL (2011)
Primary Care-Relevant Interventions to Prevent Falling in Older Adults: A Systematic Evidence Review for the U.S. Preventive Services Task Force
Yvonne L. Michael et al.
ANNALS OF INTERNAL MEDICINE (2010)
Systematic Review: Vitamin D and Calcium Supplementation in Prevention of Cardiovascular Events
Lu Wang et al.
ANNALS OF INTERNAL MEDICINE (2010)
A meta-analysis of the efficacy of raloxifene on all clinical and vertebral fractures and its dependency on FRA®
John A. Kanis et al.
BONE (2010)
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary
Alexandra Papaioannou et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2010)
Exposure to Oral Bisphosphonates and Risk of Esophageal Cancer
Chris R. Cardwell et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Annual High-Dose Oral Vitamin D and Falls and Fractures in Older Women A Randomized Controlled Trial
Kerrie M. Sanders et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Predictors of hip fractures in elderly men
Gyula Poór et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Effects of Denosumab on Bone Mineral Density and Bone Turnover in Postmenopausal Women Transitioning From Alendronate Therapy
David L. Kendler et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
The diagnosis of osteoporosis
John A. Kanis et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Atrial Fibrillation and Bisphosphonate Therapy
Michael Pazianas et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
The Effect of Prior Bisphosphonate Therapy on the Subsequent BMD and Bone Turnover Response to Strontium Ranelate
Edward T. Middleton et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Report of a Task Force of the American Society for Bone and Mineral Research
Elizabeth Shane et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Oral Bisphosphonate Use and Breast Cancer Incidence in Postmenopausal Women
Rowan T. Chlebowski et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
FRAXA® assessment of osteoporotic fracture probability in Switzerland
K. Lippuner et al.
OSTEOPOROSIS INTERNATIONAL (2010)
The cost-effectiveness of strontium ranelate in the UK for the management of osteoporosis
F. Borgstrom et al.
OSTEOPOROSIS INTERNATIONAL (2010)
The cost-effectiveness of risedronate in the UK for the management of osteoporosis using the FRAXA®
F. Borgstrom et al.
OSTEOPOROSIS INTERNATIONAL (2010)
Treatment of osteoporosis: recognizing and managing cutaneous adverse reactions and drug-induced hypersensitivity
P. Musette et al.
OSTEOPOROSIS INTERNATIONAL (2010)
Cost-Effectiveness of Osteoporosis Screening Followed by Treatment: The Impact of Medication Adherence
Mickael Hiligsmann et al.
VALUE IN HEALTH (2010)
American College of Rheumatology 2010 Recommendations for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
Jennifer M. Grossman et al.
ARTHRITIS CARE & RESEARCH (2010)
Overcoming problems with adherence to osteoporosis medication
Veronique Rabenda et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2010)
An evaluation of the NICE guidance for the prevention of osteoporotic fragility fractures in postmenopausal women
John A. Kanis et al.
Archives of Osteoporosis (2010)
Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort
Jane Green et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Predicting Risk of Osteoporotic Fracture in Men and Women in England and Wales: Prospective Derivation and Validation of QFractureScores
P. Mikosch
JOURNAL FUR MINERALSTOFFWECHSEL (2010)
Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX®
John A. Kanis et al.
BONE (2009)
Minerals and vitamins in bone health: the potential value of dietary enhancement
Jean-Philippe Bonjour et al.
BRITISH JOURNAL OF NUTRITION (2009)
Sequential Treatment of Severe Postmenopausal Osteoporosis After Teriparatide: Final Results of the Randomized, Controlled European Study of Forsteo (EUROFORS)
Richard Eastell et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK
J. Compston et al.
MATURITAS (2009)
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
Steven R. Cummings et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Incorporating adherence into health economic modelling of osteoporosis
O. Strom et al.
OSTEOPOROSIS INTERNATIONAL (2009)
The incidence and risk of hip fracture in Poland
E. Czerwinski et al.
OSTEOPOROSIS INTERNATIONAL (2009)
BMD, clinical risk factors and their combination for hip fracture prevention
H. Johansson et al.
OSTEOPOROSIS INTERNATIONAL (2009)
Closing the osteoporosis care gap – Increased osteoporosis awareness among geriatrics and rehabilitation teams
Derek A Haaland et al.
BMC Geriatrics (2009)
Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores
Julia Hippisley-Cox et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials
H. A. Bischoff-Ferrari et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Nutrition: its role in bone health
Rene Rizzoli
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
The cost-effectiveness of alendronate in the management of osteoporosis
John A. Kanis et al.
BONE (2008)
A reference standard for the description of osteoporosis
John A. Kanis et al.
BONE (2008)
Role of biochemical markers of bone turnover as prognostic indicator of successful osteoporosis therapy
Jean-Yves Reginster et al.
BONE (2008)
Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis
Rene Rizzoli et al.
BONE (2008)
Vertebral fracture assessment (VFA) with a densitometer predicts future, fractures in elderly women unselected for osteoporosis
Eugene V. McCloskey et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Efficacy of Bazedoxifene in Reducing New Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis: Results From a 3-Year, Randomized, Placebo-, and Active-Controlled Clinical Trial
Stuart L. Silverman et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Official positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Position Development Conference
Sanford Baim et al.
JOURNAL OF CLINICAL DENSITOMETRY (2008)
Early responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronate
Paul D. Miller et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Effects of previous antiresorptive therapy on the bone mineral density response to two years of teriparatide treatment in postmenopausal women with osteoporosis
Steven Boonen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Commentary: A revised clinician's guide to the prevention and treatment of osteoporosis
Bess Dawson-Hughes
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Effective Exercise for the Prevention of Falls: A Systematic Review and Meta-Analysis
Catherine Sherrington et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2008)
Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX™)
S. Fujiwara et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Cost-effective osteoporosis treatment thresholds: the United States perspective
A. N. A. Tosteson et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks
N. D. Nguyen et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA
B. Dawson-Hughes et al.
OSTEOPOROSIS INTERNATIONAL (2008)
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2008)
FRAX™ and the assessment of fracture probability in men and women from the UK
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Case finding for the management of osteoporosis with FRAX® -: assessment and intervention thresholds for the UK
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women
V. Rabenda et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Algorithm-based qualitative and semiquantitative identification of prevalent vertebral fracture: Agreement between different readers, imaging modalities, and diagnostic approaches
Lynne Ferrar et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Ibandronate and the risk of non-vertebral and clinical fractures in women with postmenopausal osteoporosis: results of a meta-analysis of phase III studies
Steven T. Harris et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
Effect of annual intramuscular vitamin D on fracture risk in elderly men and womena population-based, randomized, double-blind, placebo-controlled trial
H. Smith et al.
RHEUMATOLOGY (2007)
Relationship between change in femoral neck bone mineral density and hip fracture incidence during treatment with strontium ranelate
O. Bruyere et al.
CURRENT MEDICAL RESEARCH AND OPINION (2007)
Vitamin D supplementation and total mortality - A meta-analysis of randomized controlled trials
Philippe Autier et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis
Benjamin M. P. Tang et al.
LANCET (2007)
Single-site vs multisite bone density measurement for fracture prediction
William D. Leslie et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Relationship between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate
Olivier Bruyere et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Cost-effectiveness of alendronate in the treatment of postmenopausal women in 9 European countries -: an economic evaluation based on the fracture intervention trial
O. Strom et al.
OSTEOPOROSIS INTERNATIONAL (2007)
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2007)
Efficacy of a hip protector to prevent hip fracture in nursing home residents - The HIPPRO randomized controlled trial
Douglas P. Kiel et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate
Michael McClung et al.
BONE (2007)
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis
Dennis M. Black et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Strategies to prevent falls and fractures in hospitals and care homes and effect of cognitive impairment: systematic review and meta-analyses
David Oliver et al.
BRITISH MEDICAL JOURNAL (2007)
Role of dual-energy X-ray absorptiometry in the diagnosis and treatment of osteoporosis
Glen M. Blake et al.
JOURNAL OF CLINICAL DENSITOMETRY (2007)
Cost-effectiveness of the treatment and prevention of osteoporosis - a review of the literature and a reference model
N. Zethraeus et al.
OSTEOPOROSIS INTERNATIONAL (2007)
An age-related decrease in creatinine clearance is associated with an increase in number of falls in untreated women but not in women receiving calcitriol treatment
J. Christopher Gallagher et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Clodronate reduces the incidence of fractures in community-dwelling elderly women unselected for osteoporosis: Results of a double-blind, placebo-controlled randomized study
Eugene V. McCloskey et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Hip Fracture Prediction in Elderly Men and Women: Validation in the Rotterdam Study
Chris E. D. H. De Laet et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
An estimate of the worldwide prevalence and disability associated with osteoporotic fractures
O. Johnell et al.
OSTEOPOROSIS INTERNATIONAL (2006)
Change in lumbar spine BMD and vertebral fracture risk reduction in teriparatide-treated postmenopausal women with osteoporosis
Peiqi Chen et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Factors associated with adherence and persistence to bisphosphonate therapy in osteoporosis: a cross-sectional survey
A. J. Carr et al.
OSTEOPOROSIS INTERNATIONAL (2006)
At what hip fracture risk is it cost-effective to treat?: International intervention thresholds for the treatment of osteoporosis
F. Borgstroem et al.
OSTEOPOROSIS INTERNATIONAL (2006)
Quality and performance measures in bone densitometry -: Part 2:: Fracture risk
C. C. Glueer et al.
OSTEOPOROSIS INTERNATIONAL (2006)
Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women
Elizabeth Barrett-Connor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes - The NSABP study of tamoxifen and raloxifene (STAR) P-2 trial
Victor G. Vogel et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study
JY Reginster et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Cost-effectiveness of vertebral fracture assessment to detect prevalent vertebral deformity and select postmenopausal women with a femoral neck T-Score >-2.5 for alendronate therapy:: A modeling study
John T. Schousboe et al.
JOURNAL OF CLINICAL DENSITOMETRY (2006)
The use of multiple sites for the diagnosis of osteoporosis
JA Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2006)
Fragility fractures and the osteoporosis care gap: An international phenomenon
L Giangregorio et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2006)
Effectiveness of hip protectors for preventing hip fractures in elderly people: systematic review
MJ Parker et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
Economic evaluations of interventions for the prevention and treatment of osteoporosis: a structured review of the literature
RL Fleurence et al.
OSTEOPOROSIS INTERNATIONAL (2006)
Intravenous ibandronate injections in postmenopausal women with osteoporosis - One-year results from the dosing intravenous administration study
Pierre D. Delmas et al.
ARTHRITIS AND RHEUMATISM (2006)
Vertebral fracture assessment: The 2005 ISCD official positions
Tamara Vokes et al.
JOURNAL OF CLINICAL DENSITOMETRY (2006)
Official positions of the International Society for Clinical Densitometry and executive summary of the 2005 Position Development Conference
Neil Binkley et al.
JOURNAL OF CLINICAL DENSITOMETRY (2006)
Development of an algorithm for using PINP to monitor treatment of patients with teriparatide
R Eastell et al.
CURRENT MEDICAL RESEARCH AND OPINION (2006)
Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: Reduction in risk of nonvertebral fracture is not related to change in BMD
NB Watts et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Potential cost-effective use of spine radiographs to detect vertebral deformity and select osteopenic post-menopausal women for amino-bisphosphonate therapy
JT Schousboe et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Do hip protectors decrease the risk of hip fracture in institutional and community-dwelling elderly? A systematic review and meta-analysis of randomized controlled trials
AM Sawka et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Precision assessment and radiation safety for dual-energy X-ray absorptiometry
S Baim et al.
JOURNAL OF CLINICAL DENSITOMETRY (2005)
Compliance with osteoporosis medications
DH Solomon et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Prevention of falls and consequent injuries in elderly people
P Kannus et al.
LANCET (2005)
Body mass index as a predictor of fracture risk:: A meta-analysis
C De Laet et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Sustained nonvertebral fragility fracture risk reduction after discontinuation of teriparatide treatment
R Prince et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Parathyroid hormone (1-84) and treatment of osteoporosis
SP Shrader et al.
ANNALS OF PHARMACOTHERAPY (2005)
One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis
DM Black et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Alcohol intake as a risk factor for fracture
JA Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Predictive value of BMD for hip and other fractures
O Johnell et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Assessment of fracture risk
JA Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study
JY Reginster et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Evidence-based guidelines for the treatment of postmenopausal osteoporosis: a consensus document of the Belgian Bone Club
S Boonen et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: A comparative meta-analysis
F Richy et al.
CALCIFIED TISSUE INTERNATIONAL (2005)
Requirements for DXA for the management of osteoporosis in Europe
JA Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Smoking and fracture risk: a meta-analysis
JA Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Intervention thresholds for osteoporosis in men and women: a study based on data from Sweden
JA Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Intervention thresholds for osteoporosis in the UK
JA Kanis et al.
BONE (2005)
Effects of conjugated, equine estrogen in postmenopausal women with hysterectomy - The women's health initiative randomized controlled trial
GL Anderson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Efficacy of alphacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate
F Richy et al.
OSTEOPOROSIS INTERNATIONAL (2004)
Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures:: the PERF study
YZ Bagger et al.
BONE (2004)
Relationship between changes in bone mineral density and fracture risk reduction with antiresorptive drugs: Some issues with meta-analyses
PD Delmas et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis
PJ Meunier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review
V Elliot-Gibson et al.
OSTEOPOROSIS INTERNATIONAL (2004)
Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study
PD Delmas et al.
OSTEOPOROSIS INTERNATIONAL (2004)
Use of cost-effectiveness analysis in health-care resource allocation decision-making:: How are cost-effectiveness thresholds expected to emerge?
HG Eichler et al.
VALUE IN HEALTH (2004)
Change in bone turnover and hip, non-spine, and vertebral fracture in alendronate-treated women: The Fracture Intervention Trial
DC Bauer et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Official positions of the International Society for Clinical Densitometry
EM Lewiecki et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis
CH Chesnut et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
The impact of compliance with osteoporosis therapy on fracture rates in actual practice
JJ Caro et al.
OSTEOPOROSIS INTERNATIONAL (2004)
Fundamentals and pitfalls of bone densitometry using dual-energy X-ray absorptiometry (DXA)
NB Watts
OSTEOPOROSIS INTERNATIONAL (2004)
A family history of fracture and fracture risk: a meta-analysis
JA Kanis et al.
BONE (2004)
A meta-analysis of prior corticosteroid use and fracture risk
JA Kanis et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Optimization of BMD measurements to identify high risk groups for treatment - A test analysis
H Johansson et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Clodronate reduces vertebral fracture risk in women with postmenopausal or secondary osteoporosis:: Results of a double-blind, placebo-controlled 3-year study
E McCloskey et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Does the combination of two BMD measurements improve fracture discrimination?
GM Blake et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
Effects of estrogen plus progestin on risk of fracture and bone mineral density - The Women's Health Initiative randomized trial
JA Cauley et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial
PD Delmas et al.
BONE (2003)
The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis
DM Black et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Effect of raloxifene on the risk of new vertebral fracture in postmenopausal women with osteopenia or osteoporosis: a reanalysis of the Multiple Outcomes of Raloxifene Evaluation trial
JA Kanis et al.
BONE (2003)
Effect of withdrawal of hormone replacement therapy on bone mass and bone turnover: the OFELY study
E Sornay-Rendu et al.
BONE (2003)
Influence of estrogen plus progestin on breast, cancer and mammography in healthy postmenopausal women - The Women's Health Initiative Randomized trial
RT Chlebowski et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate
R Eastell et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women - The Women's Health Initiative Memory Study: A randomized controlled trial
SA Shumaker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Effect of estrogen plus progestin on stroke in postmenopausal women - The Women's Health Initiative: A randomized trial
S Wassertheil-Smoller et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Effects of estrogen plus progestin on health-related quality of life
J Hays et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
The components of excess mortality after hip fracture
JA Kanis et al.
BONE (2003)
Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): An update
S Tas et al.
DERMATOLOGY (2003)
Meta-analysis of calcitonin for the treatment of postmenopausal osteoporosis
A Cranney et al.
ENDOCRINE REVIEWS (2002)
Summary of meta-analyses of therapies for postmenopausal osteoporosis
A Cranney et al.
ENDOCRINE REVIEWS (2002)
Risks and benefits of estrogen plus progestin in healthy postmenopausal women - Principal results from the Women's Health Initiative randomized controlled trial
JE Rossouw et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Intervention thresholds for osteoporosis
JA Kanis et al.
BONE (2002)
International variations in hip fracture probabilities: Implications for risk assessment
JA Kanis et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2002)
Treatment of postmenopausal osteoporosis
PD Delmas
LANCET (2002)
Diagnosis of osteoporosis and assessment of fracture risk
JA Kanis
LANCET (2002)
Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents
MC Hochberg et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Intravenous zoledronic acid in postmenopausal women with low bone mineral density.
IR Reid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs
SR Cummings et al.
AMERICAN JOURNAL OF MEDICINE (2002)
Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy
S Sarkar et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2002)
Design and methods of the raloxifene use for the heart (RUTH) study
L Mosca et al.
AMERICAN JOURNAL OF CARDIOLOGY (2001)
Hormone replacement therapy and prevention of nonvertebral fractures - A meta-analysis of randomized trials
DJ Torgerson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.
RM Neer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Effect of risedronate on the risk of hip fracture in elderly women
MR McClung et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
The burden of osteoporotic fractures: A method for setting intervention thresholds
JA Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2001)
Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds
JA Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2001)
Six and twelve month changes in bone turnover are related to reduction in vertebral fracture risk during 3 years of raloxifene treatment in postmenopausal osteoporosis
NH Bjarnason et al.
OSTEOPOROSIS INTERNATIONAL (2001)
Patients with prior fractures have an increased risk of future fractures: A summary of the literature and statistical synthesis
CM Klotzbuecher et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2000)
Risk of hip fracture according to the World Health Organization criteria for osteopenia and osteoporosis
JA Kanis et al.
BONE (2000)
A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study
CH Chesnut et al.
AMERICAN JOURNAL OF MEDICINE (2000)
Use of oral corticosteroids and risk of fractures
TP Van Staa et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2000)
Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis
JY Reginster et al.
OSTEOPOROSIS INTERNATIONAL (2000)
An update on the diagnosis and assessment of osteoporosis with densitometry
JA Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2000)
Long-term risk of osteoporotic fracture in Malmo
JA Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2000)
The use of biochemical markers of bone turnover in osteoporosis
PD Delmas et al.
OSTEOPOROSIS INTERNATIONAL (2000)
Diagnosis of osteoporosis: Respective roles of biomarkers and bone density measurements: State of the art
PD Delmas
OSTEOPOROSIS INTERNATIONAL (2000)
分享论文
